CC
MRSN

Commodore Capital’s Mersana Therapeutics MRSN Stock Holding History

Commodore Capital’s Portfolio MRSN Stock Details MRSN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
2023
Q3 		$2.85M Buy
2021
Q3 		– Sell
2021
Q2 		$5.83M Hold
2021
Q1 		$6.95M Buy
2020
Q4 		$4.23M Buy